The global radiology procedures market size was estimated at USD 266.7 billion in 2025 and is estimated to reach at USD 356.5 billion by 2033, growing at a CAGR of 3.6% from 2026 to 2033. This robust growth is driven by increasing demand for early and accurate diagnosis, rising prevalence of chronic and lifestyle-related diseases, and rapid technological advancements in imaging modalities such as CT, and digital X-ray systems.
In addition, the expansion of healthcare infrastructure, growing awareness of preventive healthcare, and rising investments by key market players are expected to propel the market. Conditions such as cancer, cardiovascular diseases, neurological disorders, and diabetes require early, accurate, and non-invasive diagnosis, positioning radiology at the core of modern clinical decision-making. As healthcare systems prioritize early detection, precision medicine, and outcome-based care, reliance on imaging procedures continues to intensify across screening, diagnosis, treatment planning, and long-term monitoring.
Cancer remains one of the strongest demand generators for radiological procedures. According to the U.S. National Center for Health Statistics, approximately 1,958,310 new cancer cases and 609,820 cancer-related deaths were reported in the U.S. in 2023. Imaging modalities such as CT, X-ray, and mammography are indispensable throughout the oncology care pathway, supporting population screening, tumor detection, staging, surgical planning, treatment response assessment, and post-therapy surveillance. Surgeons increasingly depend on preoperative CT and MRI to accurately delineate tumor size, margins, and anatomical relationships, directly improving surgical precision and patient outcomes. As cancer incidence continues to rise globally, imaging volumes are expected to grow proportionally.
Moreover, the rapidly aging global population accelerating demand for radiology procedures worldwide. Older adults face a significantly higher risk of chronic illnesses, disabilities, and degenerative conditions, making diagnostic imaging essential for early detection, disease monitoring, and clinical decision-making. Multiple NCBI studies confirm that individuals aged 65 years and above are more susceptible to neurological disorders, Parkinson’s disease, cardiovascular conditions, and musculoskeletal degeneration, all of which rely heavily on radiological evaluation. Demographic trends reinforce this demand surge. According to the World Health Organization (WHO), the global population aged 60 years and above increased from approximately 1 billion in 2020 to around 1.4 billion by 2030 and is expected to nearly double to 2.1 billion by 2050. This expansion is accompanied by a sharp rise in elderly patients with multiple comorbidities, including stroke, depression, dementia, and frailty. Age-related changes in muscle mass, bone density, and body composition increase the risk of falls, fractures, and injuries, directly driving demand for X-ray and CT-based diagnostic procedures in both emergency and routine care settings.
Rapid technological innovation is a powerful driver accelerating growth in the radiological procedures market, as advances in materials science, detector design, and artificial intelligence are transforming imaging performance, cost structures, and clinical workflows. Continuous improvements in X-ray detection technologies and AI-enabled imaging systems are expanding clinical applications, improving diagnostic accuracy, and increasing procedure volumes across hospitals and diagnostic imaging centers.
A notable example of next-generation innovation emerged in February 2026, when researchers at Florida State University (FSU) announced the development of new hybrid materials for advanced X-ray technologies. Led by Professor Biwu Ma, the research introduced organic metal halide complexes (OMHCs) and organic metal halide hybrids (OMHHs) a new class of materials that address longstanding limitations of conventional inorganic X-ray detectors. Traditional materials such as cadmium telluride (CdTe) and cadmium zinc telluride (CdZnTe) are rigid, expensive, energy-intensive to manufacture, and rely on toxic elements, which constrain scalability and sustainability.
This product will be delivered within 1-3 business days.
In addition, the expansion of healthcare infrastructure, growing awareness of preventive healthcare, and rising investments by key market players are expected to propel the market. Conditions such as cancer, cardiovascular diseases, neurological disorders, and diabetes require early, accurate, and non-invasive diagnosis, positioning radiology at the core of modern clinical decision-making. As healthcare systems prioritize early detection, precision medicine, and outcome-based care, reliance on imaging procedures continues to intensify across screening, diagnosis, treatment planning, and long-term monitoring.
Cancer remains one of the strongest demand generators for radiological procedures. According to the U.S. National Center for Health Statistics, approximately 1,958,310 new cancer cases and 609,820 cancer-related deaths were reported in the U.S. in 2023. Imaging modalities such as CT, X-ray, and mammography are indispensable throughout the oncology care pathway, supporting population screening, tumor detection, staging, surgical planning, treatment response assessment, and post-therapy surveillance. Surgeons increasingly depend on preoperative CT and MRI to accurately delineate tumor size, margins, and anatomical relationships, directly improving surgical precision and patient outcomes. As cancer incidence continues to rise globally, imaging volumes are expected to grow proportionally.
Moreover, the rapidly aging global population accelerating demand for radiology procedures worldwide. Older adults face a significantly higher risk of chronic illnesses, disabilities, and degenerative conditions, making diagnostic imaging essential for early detection, disease monitoring, and clinical decision-making. Multiple NCBI studies confirm that individuals aged 65 years and above are more susceptible to neurological disorders, Parkinson’s disease, cardiovascular conditions, and musculoskeletal degeneration, all of which rely heavily on radiological evaluation. Demographic trends reinforce this demand surge. According to the World Health Organization (WHO), the global population aged 60 years and above increased from approximately 1 billion in 2020 to around 1.4 billion by 2030 and is expected to nearly double to 2.1 billion by 2050. This expansion is accompanied by a sharp rise in elderly patients with multiple comorbidities, including stroke, depression, dementia, and frailty. Age-related changes in muscle mass, bone density, and body composition increase the risk of falls, fractures, and injuries, directly driving demand for X-ray and CT-based diagnostic procedures in both emergency and routine care settings.
Rapid technological innovation is a powerful driver accelerating growth in the radiological procedures market, as advances in materials science, detector design, and artificial intelligence are transforming imaging performance, cost structures, and clinical workflows. Continuous improvements in X-ray detection technologies and AI-enabled imaging systems are expanding clinical applications, improving diagnostic accuracy, and increasing procedure volumes across hospitals and diagnostic imaging centers.
A notable example of next-generation innovation emerged in February 2026, when researchers at Florida State University (FSU) announced the development of new hybrid materials for advanced X-ray technologies. Led by Professor Biwu Ma, the research introduced organic metal halide complexes (OMHCs) and organic metal halide hybrids (OMHHs) a new class of materials that address longstanding limitations of conventional inorganic X-ray detectors. Traditional materials such as cadmium telluride (CdTe) and cadmium zinc telluride (CdZnTe) are rigid, expensive, energy-intensive to manufacture, and rely on toxic elements, which constrain scalability and sustainability.
Global Radiology Procedures Market Report Segmentation
This report forecasts revenue growth at global levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. Forthis study, the analyst has segmented the global radiology procedures market report based on modality, end use, and region:Modality Outlook (Revenue, USD Million, 2021-2033)
- X-Ray
- Mammography
- Computed Tomography
End Use Outlook (Revenue, USD Million, 2021-2033)
- Hospitals
- Diagnostic Imaging Centers
- Others
Region Outlook (Revenue, USD Million, 2021-2033)
- International
- U.S.
Why You Should Buy This Report
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Radiology Procedures Market Variables, Trends & Scope
Chapter 4. Radiology Procedures Market: Modality Estimates & Trend Analysis
Chapter 5. Radiology Procedures Market: End Use Estimates & Trend Analysis
Chapter 6. Radiology Procedures Market: Regional Estimates & Trend Analysis
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The leading players profiled in this Radiology Procedures market report include:- GE HealthCare
- Siemens Healthcare GmbH
- Koninklijke Philips N.V.
- Canon Medical Systems
- Hologic, Inc
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd
- FUJIFILM VisualSonics Inc.
- AGFA HealthCare
- Shimadzu Corporation
- Carestream Health
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 110 |
| Published | February 2026 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 266.7 Billion |
| Forecasted Market Value ( USD | $ 356.5 Billion |
| Compound Annual Growth Rate | 3.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
